Bicycle Therapeutics PLC (BCYC)
20.53
+0.27
(+1.33%)
USD |
NASDAQ |
Nov 22, 14:43
Bicycle Therapeutics Total Liabilities (Quarterly): 165.71M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 165.71M |
| June 30, 2024 | 183.54M |
| March 31, 2024 | 191.10M |
| December 31, 2023 | 224.41M |
| September 30, 2023 | 222.66M |
| June 30, 2023 | 234.07M |
| March 31, 2023 | 185.64M |
| December 31, 2022 | 139.83M |
| September 30, 2022 | 127.67M |
| June 30, 2022 | 134.09M |
| March 31, 2022 | 129.30M |
| December 31, 2021 | 133.54M |
| Date | Value |
|---|---|
| September 30, 2021 | 110.51M |
| June 30, 2021 | 84.00M |
| March 31, 2021 | 81.75M |
| December 31, 2020 | 65.69M |
| September 30, 2020 | 60.51M |
| June 30, 2020 | 47.58M |
| March 31, 2020 | 47.47M |
| December 31, 2019 | 17.00M |
| September 30, 2019 | 20.74M |
| June 30, 2019 | 21.69M |
| March 31, 2019 | 20.89M |
| December 31, 2018 | 151.45M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
17.00M
Minimum
Dec 2019
234.07M
Maximum
Jun 2023
129.30M
Average
131.42M
Median
Total Liabilities (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 237.45M |
| NuCana PLC | 20.58M |
| TC BioPharm (Holdings) PLC | 7.807M |
| Autolus Therapeutics PLC | 350.52M |
| Biodexa Pharmaceuticals PLC | 6.628M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 996.75M |
| Shareholders Equity (Quarterly) | 831.03M |
| Current Ratio | 17.13 |
| Net Debt Paydown Yield | 0.39% |